Search Results - "Siegmund, B"

Refine Results
  1. 1
  2. 2

    Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do’s and Don’ts from the ECCO-COVID Taskforce by Magro, F, Rahier, J-F, Abreu, C, MacMahon, E, Hart, A, van der Woude, C J, Gordon, H, Adamina, M, Viget, N, Vavricka, S, Kucharzik, T, Leone, S, Siegmund, B, Danese, S, Peyrin-Biroulet, L

    Published in Journal of Crohn's and colitis (21-10-2020)
    “…Abstract Our knowledge of COVID-19 is changing and evolving rapidly, with novel insights and recommendations, almost on a daily basis. It behooves the medical…”
    Get full text
    Journal Article
  3. 3

    Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs by Strangfeld, A, Richter, A, Siegmund, B, Herzer, P, Rockwitz, K, Demary, W, Aringer, M, Meißner, Y, Zink, A, Listing, J

    Published in Annals of the rheumatic diseases (01-03-2017)
    “…To investigate the risk of developing lower intestinal perforations (LIPs) in patients with rheumatoid arthritis (RA) treated with tocilizumab (TCZ). In 13 310…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Reconstruction of the temporomandibular joint: a comparison between prefabricated and customized alloplastic prosthetic total joint systems by Siegmund, B.J., Winter, K., Meyer-Marcotty, P., Rustemeyer, J.

    “…The implantation of an alloplastic total temporomandibular joint (TMJ) prosthesis is an innovative approach for the treatment of end-stage TMJ disorders. Two…”
    Get full text
    Journal Article
  6. 6

    Faecal microbiota transplantation—A clinical view by Mattner, J, Schmidt, F, Siegmund, B

    “…Highlights • Faecal microbiota transplantation is curative for Clostridium difficile infection. • The intestinal microbiota in inflammatory bowel disease has a…”
    Get full text
    Journal Article
  7. 7

    European Study on Orthopaedic Status of haemophilia patients with inhibitors by MORFINI, M., HAYA, S., TAGARIELLO, G., POLLMANN, H., QUINTANA, M., SIEGMUND, B., STIELTJES, N., DOLAN, G., TUSELL, J.

    “…Development of inhibitors against factor VIII (FVIII) or factor IX (FIX) in haemophilia patients is one of the most serious complications of repeated exposure…”
    Get full text
    Journal Article
  8. 8

    Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review by Volz, M S, Siegmund, B, Häuser, W

    Published in Schmerz (Berlin, Germany) (01-02-2016)
    “…The medical use of cannabis is discussed in gastroenterology for inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), and chronic pancreatitis. A…”
    Get full text
    Journal Article
  9. 9

    Adipokine signaling in inflammatory bowel disease by Batra, A., Zeitz, M., Siegmund, B.

    Published in Inflammatory bowel diseases (01-12-2009)
    “…: While the incidence of inflammatory bowel disease (IBD) is still increasing, the etiology has not finally been dissected. The main hypothesis suggests that…”
    Get full text
    Journal Article
  10. 10

    Campylobacter jejuni impairs sodium transport and epithelial barrier function via cytokine release in human colon by Bücker, R, Krug, S M, Moos, V, Bojarski, C, Schweiger, M R, Kerick, M, Fromm, A, Janßen, S, Fromm, M, Hering, N A, Siegmund, B, Schneider, T, Barmeyer, C, Schulzke, J D

    Published in Mucosal immunology (01-03-2018)
    “…Campylobacter jejuni is the most prevalent cause of foodborne bacterial enteritis worldwide. Patients present with diarrhea and immune responses lead to…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Spatio-temporal variability of sugarcane fields and recommendations for yield forecast using NDVI by Bégué, A., Lebourgeois, V., Bappel, E., Todoroff, P., Pellegrino, A., Baillarin, F., Siegmund, B.

    Published in International journal of remote sensing (01-06-2010)
    “…Sugarcane is a semi-perennial grass whose cultivation is characterized by an extended harvest season lasting several months leading to very high…”
    Get full text
    Journal Article
  14. 14

    High prevalence and functional effects of serum antineuronal antibodies in patients with gastrointestinal disorders by Lütt, A., Michel, K., Krüger, D., Volz, M. S., Nassir, M., Schulz, E., Poralla, L., Tangermann, P., Bojarski, C., Höltje, M., Teegen, B., Stöcker, W., Schemann, M., Siegmund, B., Prüss, H.

    Published in Neurogastroenterology and motility (01-06-2018)
    “…Background Antineuronal antibodies can be associated with both gastrointestinal (GI) and brain disorders. For example, antibodies against the potassium channel…”
    Get full text
    Journal Article
  15. 15

    Patient Education in a 14-month Randomised Trial Fails to Improve Adherence in Ulcerative Colitis: Influence of Demographic and Clinical Parameters on Non-adherence by Nikolaus, S, Schreiber, S, Siegmund, B, Bokemeyer, B, Bästlein, E, Bachmann, O, Görlich, D, Hofmann, U, Schwab, M, Kruis, W

    Published in Journal of Crohn's and colitis (01-09-2017)
    “…Abstract Background and Aim Recent observational studies document that non-adherence to mesalamine therapy during remission is frequent. We aimed to…”
    Get full text
    Journal Article
  16. 16

    Architectural and functional alterations of the small intestinal mucosa in classical Whipple’s disease by Epple, H-J, Friebel, J, Moos, V, Troeger, H, Krug, S M, Allers, K, Schinnerling, K, Fromm, A, Siegmund, B, Fromm, M, Schulzke, J D, Schneider, T

    Published in Mucosal immunology (01-11-2017)
    “…Classical Whipple’s disease (CWD) affects the gastrointestinal tract and rather elicits regulatory than inflammatory immune reactions. Mechanisms of…”
    Get full text
    Journal Article
  17. 17

    Mesenteric fat—control site for bacterial translocation in colitis? by Batra, A, Heimesaat, M M, Bereswill, S, Fischer, A, Glauben, R, Kunkel, D, Scheffold, A, Erben, U, Kühl, A, Loddenkemper, C, Lehr, H-A, Schumann, M, Schulzke, J-D, Zeitz, M, Siegmund, B

    Published in Mucosal immunology (01-09-2012)
    “…In Crohn's disease bacteria could be detected in the adjacent mesenteric fat characterized by hypertrophy of unknown function. This study aimed to define…”
    Get full text
    Journal Article
  18. 18

    Imbalance between interleukin‐1 agonists and antagonists: relationship to severity of inflammatory bowel disease by LUDWICZEK, O., VANNIER, E., BORGGRAEFE, I., KASER, A., SIEGMUND, B., DINARELLO, C. A., TILG, H.

    Published in Clinical and experimental immunology (01-11-2004)
    “…SUMMARY Interleukin (IL)‐1 is a key mediator in the pathogenesis of inflammatory bowel disease (IBD). Naturally occurring IL‐1 modulators include IL‐1 receptor…”
    Get full text
    Journal Article
  19. 19
  20. 20